Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Transfusion. 2014 Oct 14;55(3):674–679. doi: 10.1111/trf.12881

Table 1.

Cell product types manufactured for clinical use and total number of product administration data forms collected.

A subset of the total number of administrations by each cell product type occurring since 2010, during which the request for outcome data collection began, is indentified in the table.

Cell Product Type Product Administration Forms (2003-2014) Product Administration Forms (2010-2014)* Post-Product Administration (Outcome) Data Forms
Month 3 Month 6 Month 12
Bone marrow mononuclear cells (BM-MNCs) 240 141 26 25 23
Cytotoxic T lymphocytes (CTLs) 209 132 9 8 1
Natural killer (NK) cells 77 15 13 6 1
Dendritic cells (DCs) 49 0 0 0 0
T regulatory cells (Tregs) 46 5 3 1 0
Hematopoietic stem cells (HSCs) 29 29 29 23 21
Mesenchymal stem/stromal cells (MSCs) 13 13 10 2 0
CD133+ progenitor cells 2 2 0 0 0
Total forms collected 665 337 90 65 46
*

Outcome data collection began in 2010